Product
SRP-6004
1 clinical trial
1 indication
Indication
Limb-Girdle Muscular DystrophyClinical trial
An Open-Label, Systemic Gene Transfer Study to Evaluate the Safety, Tolerability, and Efficacy of SRP 6004 Administered by Systemic Infusion in Ambulatory Subjects With Limb Girdle Muscular Dystrophy Type 2B/R2 (LGMD2B/R2, Dysferlin Related)Status: Active (not recruiting), Estimated PCD: 2028-08-31